{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:39:27Z","timestamp":1787582367373,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008385","name":"Fondazione per la Ricerca sulla Fibrosi Cistica","doi-asserted-by":"publisher","award":["9\/2018"],"award-info":[{"award-number":["9\/2018"]}],"id":[{"id":"10.13039\/501100008385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008385","name":"Fondazione per la Ricerca sulla Fibrosi Cistica","doi-asserted-by":"publisher","award":["14\/2022"],"award-info":[{"award-number":["14\/2022"]}],"id":[{"id":"10.13039\/501100008385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijbiomac.2026.150145","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:09:27Z","timestamp":1767802167000},"page":"150145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P1","title":["Therapeutic potential of a long-acting form of rhDNase I for the treatment of cystic fibrosis"],"prefix":"10.1016","volume":"340","author":[{"given":"Antonella","family":"Grigoletto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danila","family":"Delfino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Bizzotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Campara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Natalia","family":"Calienni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Buttini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Glieca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia Della","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Tedeschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Casciaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Tirelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Percudani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Pasut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.150145_bb0005","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0010","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1126\/science.2997931","article-title":"Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker","volume":"230","author":"Tsui","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mib.2006.12.005","article-title":"Neutrophil extracellular traps: casting the NET over pathogenesis","volume":"10","author":"Wartha","year":"2007","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0020","doi-asserted-by":"crossref","first-page":"R88","DOI":"10.1093\/hmg\/ddz139","article-title":"Advances in gene therapy for cystic fibrosis lung disease","volume":"28","author":"Yan","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.662110","article-title":"On the corner of models and cure: gene editing in cystic fibrosis","volume":"12","author":"Ensinck","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2026.150145_bb0030","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jcf.2014.03.010","article-title":"European cystic fibrosis society, European cystic fibrosis society standards of care: best practice guidelines","volume":"13","author":"Smyth","year":"2014","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0035","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ppul.21388","article-title":"Scientific advisory group and investigators and coordinators of epidemiologic study of cystic fibrosis, clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis","volume":"46","author":"Konstan","year":"2011","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0040","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s10495-007-0078-4","article-title":"Inhibition of deoxyribonuclease I by actin is to protect cells from premature cell death","volume":"12","author":"Eulitz","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0045","series-title":"Pharm. Biotechnol., Springer International Publishing, Cham","first-page":"471","article-title":"Recombinant Human Deoxyribonuclease I","author":"Lazarus","year":"2019"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0050","article-title":"The evolution of polymer conjugation and drug targeting for the delivery of proteins and bioactive molecules","author":"Grigoletto","year":"2020","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0055","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jconrel.2011.10.037","article-title":"State of the art in PEGylation: the great versatility achieved after forty years of research","volume":"161","author":"Pasut","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0060","article-title":"Polymer-protein conjugates: from pegylation and beyond","author":"Pasut","year":"2019","journal-title":"Elsevier"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijpharm.2017.03.057","article-title":"Production and characterization of a PEGylated derivative of recombinant human deoxyribonuclease I for cystic fibrosis therapy","volume":"524","author":"Guichard","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0070","doi-asserted-by":"crossref","first-page":"2000146","DOI":"10.1002\/adtp.202000146","article-title":"PEGylation of recombinant human Deoxyribonuclease I provides a long-acting version of the mucolytic for patients with cystic fibrosis","volume":"4","author":"Guichard","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120107","article-title":"PEGylation of recombinant human deoxyribonuclease I decreases its transport across lung epithelial cells and uptake by macrophages","volume":"593","author":"Mahri","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0080","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","article-title":"Addressing the PEG Mucoadhesivity paradox to engineer nanoparticles that \u201cslip\u201d through the human mucus barrier","volume":"47","author":"Wang","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1970","key":"10.1016\/j.ijbiomac.2026.150145_bb0085","first-page":"680","article-title":"Laemmli, cleavage of structural proteins during assembly of head of bacteriophage-T4","volume":"227","author":"U.K.","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0090","series-title":"Methods in Molecular Biology (Methods and Protocols)","author":"Mero","year":"2011"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0095","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.1039\/C6PY01616B","article-title":"Site-selective enzymatic chemistry for polymer conjugation to protein lysine residues: PEGylation of G-CSF at lysine-41","volume":"7","author":"Mero","year":"2016","journal-title":"Polym. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1085\/jgp.33.4.363","article-title":"Crystalline desoxyribonuclease; digestion of thymus nucleic acid; the kinetics of the reaction","volume":"33","author":"Kunitz","year":"1950","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/biom11030410","article-title":"Actin-resistant DNase1L2 as a potential therapeutics for CF lung disease","volume":"11","author":"Delfino","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11095-009-9991-2","article-title":"Inhalable antibiotic delivery using a dry powder co-delivering recombinant Deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis","volume":"27","author":"Yang","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0115","series-title":"Structure of recombinant human DNase I (rhDNaseI) in complex with Magnesium and Phosphate., Worldw. Protein Data Bank","author":"Parsiegla","year":"2013"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0120","doi-asserted-by":"crossref","first-page":"10250","DOI":"10.1021\/bi300873f","article-title":"The structure of human DNase I bound to magnesium and phosphate ions points to a catalytic mechanism common to members of the DNase I-like superfamily","volume":"51","author":"Parsiegla","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0125","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/mabi.201500282","article-title":"Chemical and enzymatic site specific PEGylation of hGH: the stability and in vivo activity of PEG-N-terminal-hGH and PEG-Gln141-hGH conjugates","volume":"16","author":"Grigoletto","year":"2016","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jconrel.2014.05.008","article-title":"A hyaluronic acid-salmon calcitonin conjugate for the local treatment of osteoarthritis: Chondro-protective effect in a rabbit model of early OA","volume":"187","author":"Mero","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0135","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/321620a0","article-title":"Structure of DNase I at 2.0 a resolution suggests a mechanism for binding to and cutting DNA","volume":"321","author":"Suck","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0140","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.1021\/bi962960x","article-title":"Engineering hyperactive variants of human deoxyribonuclease I by altering its functional mechanism","volume":"36","author":"Pan","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0145","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.1073\/pnas.87.23.9188","article-title":"Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum","volume":"87","author":"Shak","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0150","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1016\/S0021-9258(19)85765-4","article-title":"The effect of divalent cations on the mode of action of DNase I. The initial reaction products produced from covalently closed circular DNA","volume":"255","author":"Campbell","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0155","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0021-9258(19)41672-4","article-title":"The essential role of Ca2+ in the activity of bovine pancreatic deoxyribonuclease","volume":"250","author":"Price","year":"1975","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0160","doi-asserted-by":"crossref","first-page":"10250","DOI":"10.1021\/bi300873f","article-title":"The structure of human DNase I bound to magnesium and phosphate ions points to a catalytic mechanism common to members of the DNase I-like superfamily","volume":"51","author":"Parsiegla","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0165","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1021\/bi001041a","article-title":"Characterization of human DNase I family endonucleases and activation of DNase gamma during apoptosis","volume":"40","author":"Shiokawa","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0170","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1073\/pnas.71.12.4742","article-title":"Actin is the naturally occurring inhibitor of deoxyribonuclease I","volume":"71","author":"Lazarides","year":"1974","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0175","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1126\/science.8310295","article-title":"Reduction in viscosity of cystic fibrosis sputum in vitro by Gelsolin","volume":"263","author":"Vasconcellos","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0180","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1196\/annals.1415.006","article-title":"The role of DNA and actin polymers on the polymer structure and rheology of cystic fibrosis sputum and depolymerization by gelsolin or thymosin beta 4","volume":"1112","author":"Kater","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/347037a0","article-title":"Atomic structure of the actin:DNase I complex","volume":"347","author":"Kabsch","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0190","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0092-8674(76)90203-8","article-title":"Depolymerization of F-actin by deoxyribonuclease I","volume":"7","author":"Hitchcock","year":"1976","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0195","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1042\/CS20180315","article-title":"Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputum","volume":"132","author":"Guichard","year":"2018","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0200","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1432-1327.2000.01023.x","article-title":"Thermal unfolding of G-actin monitored with the DNase I-inhibition assay stabilities of actin isoforms","volume":"267","author":"Sch\u00fcler","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0205","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0092-8674(78)90277-5","article-title":"Selective assay of monomeric and filamentous actin in cell extracts, using inhibition of deoxyribonuclease I","volume":"15","author":"Blikstad","year":"1978","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0210","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/jbm.a.36251","article-title":"Rheological properties of synthetic mucus for airway clearance","volume":"106","author":"Lafforgue","year":"2018","journal-title":"J. Biomed. Mater. Res. Part A."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0215","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/jbm.a.34851","article-title":"Synthetic tracheal mucus with native rheological and surface tension properties","volume":"102","author":"Hamed","year":"2014","journal-title":"J. Biomed. Mater. Res. Part A."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0220","doi-asserted-by":"crossref","DOI":"10.1098\/rsfs.2022.0028","article-title":"Mucus from human bronchial epithelial cultures: rheology and adhesion across length scales","volume":"12","author":"Jory","year":"2022","journal-title":"Interface Focus."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0225","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0230","first-page":"563","article-title":"A rheological evaluation of various mucus gels for use in in-vitro Mucoadhesion testing","volume":"2","author":"Madsen","year":"1996","journal-title":"Pharm. Pharmacol. Commun."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0235","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1749-6632.1963.tb16677.x","article-title":"HUMAN PULMONARY SECRETIONS IN HEALTH AND DISEASE","volume":"106","author":"Potter","year":"1963","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0240","first-page":"8","article-title":"Observations of, and insights into, cystic fibrosis mucus heterogeneity in the pre-modulator era: sputum characteristics, DNA and glycoprotein content, and Solubilization time","volume":"1","author":"Chance","year":"2020","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0245","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijpharm.2016.02.005","article-title":"Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients","volume":"502","author":"Buttini","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0250","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jps.22231","article-title":"A technical feasibility study of Dornase alfa delivery with eFlow\u00ae vibrating membrane nebulizers: aerosol characteristics and physicochemical stability","volume":"100","author":"Scherer","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150145_bb0255","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ppul.20048","article-title":"Effect of DNase on exercise capacity in cystic fibrosis","volume":"38","author":"Barker","year":"2004","journal-title":"Pediatr. Pulmonol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026000711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026000711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:37:21Z","timestamp":1777484241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026000711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":51,"alternative-id":["S0141813026000711"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150145","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of a long-acting form of rhDNase I for the treatment of cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"150145"}}